Diindolylmethane

N/A

Report date: 2022/08/25 20:08:35
NME

Base Information

Drug NameDiindolylmethane
Drug Alias Name二基甲烷二吲哚基甲烷二吲哚甲烷二聚吲哚BR-DIM +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAndrogen Receptor antagonists
TargetsAndrogen Receptor
Therapy Area/IndicationsLupus Erythematosus, SystemicUterine Cervical IncompetencePrecancerous Conditions +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNational Cancer Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNewyork Presbyterian HospitalBarbara Ann Karmanos Cancer InstituteBarts And The London School Of Medicine And Dentistry +[5] 
Active IndicationsN/A
Inactive IndicationsLupus Erythematosus, SystemicUterine Cervical IncompetencePrecancerous Conditions +[6] 

Other Information

ATC CodeN/A
Related LinksWikipedia